News | RIVM

RIVM launches study on long-term effectiveness of COVID-19 vaccines

RIVM is launching an extensive study today to research the long-term effectiveness of the various COVID-19 vaccines in the Netherlands.

Situation in the Netherlands remains concerning

In the week from 10 to 16 March, 39,527 people received a positive test result for COVID-19, nearly 25% more than in the week before that. The reproduction number completely above 1 this week.

Sander Koning

Prospects not looking good yet

The number of people who were tested for SARS-CoV-2 increased by 20% last week. The number of people who tested positive rose by 7%. The reproduction number also rose above 1.

RIVM collaborates at European level on the implemention of the Nutri-Score label

The Netherlands, Belgium, France, Germany, Luxembourg, Spain and Switzerland are collaborating to facilitate the nutritional label NutriScore.

Care workers in nursing homes and small-scale residential facilities invited for COVID-19 vaccination starting today

As of today, the ca. 269,000 care workers of nursing homes and small-scale residential facilities in the Netherlands are invited to make an appointment for a COVID-19 vaccination.

Discussion regarding health-based guidance value of PFOA

The European Food Safety Authority (EFSA) has published a provisional health-based guidance value for perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA).

Less meat and more tap water benefits health and the environment

In the Netherlands, diets with a high environmental impact contain more meat and energy.

Risks of potential release of genetically modified mosquitoes evaluated

On Saba, a Dutch Caribbean island, diseases such as dengue, chikungunya and zika can be reduced by the use of genetically modified mosquitoes.

Chikungunya infections in the Caribbean region

Since August 2014, there has been an increase in the number of Chikungunya patients in the Caribbean region. Travellers who visit the region can become infected there.